Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Clinical Immunology · Alopecia With Antibody Deficiency

Finding the Cause: Your Diagnostic Roadmap

At a Glance

When hair loss occurs with antibody deficiency, testing examines immune function, the scalp and hair follicles, adrenal and parathyroid hormones, and genes such as NFKB2, AIRE, and FOXN1. Specialists use the results to distinguish CVID from rare genetic syndromes.

When you have both hair loss and an immune system that doesn’t make enough antibodies, the diagnostic process is like a detective story. Because this combination is rare, your medical team needs to look at three different “scenes” at once: your immune system, your skin, and your hormone-producing glands.

This multidisciplinary approach is the only way to tell if you have a common co-occurrence (like CVID) or a rare genetic syndrome (like NFKB2 deficiency or APECED).

Branch 1: The Immunology Workup

The first goal is to confirm if your antibody deficiency is persistent and functional, after ruling out secondary causes (like protein loss, medications, or HIV). Your immunologist will typically order:

  • Quantitative Immunoglobulins: A blood test to measure the total amount of IgG, IgA, and IgM in your system. This is usually repeated to ensure age-appropriate ranges [1].
  • Vaccine Response Testing: This must be planned and interpreted by an immunologist. You receive a vaccine and have your blood checked later to see if your body successfully built protective antibodies. (Caveat: Immunoglobulin replacement can confound results, and vaccination may be unsafe in suspected significant T-cell deficiency) [2][3].
  • Flow Cytometry (Lymphocyte Subsets): This detailed test counts your different types of white blood cells. Doctors look specifically for switched-memory B-cells. If these are reduced, it can support a CVID phenotype, though it is not required nor specific [4][5].
  • T-cell Function: If a more severe syndrome is suspected, they may test how well your T-cells multiply when they encounter a trigger [6].

Branch 2: The Dermatology Workup

The dermatologist’s job is to determine the exact “flavor” of your hair loss. (A negative genetic panel does not establish CVID, and alternative diagnoses like tinea, telogen effluvium, or androgenetic hair loss must be excluded).

  • Clinical Exam & Pull Test: The doctor will examine the pattern of hair loss (patchy vs. total) and gently tug on hairs to see if they are in an active shedding phase [7].
  • Trichoscopy: Using a specialized magnifying tool, the doctor looks for specific shapes, such as exclamation mark hairs (common in Alopecia Areata) or black dots [8][9].
  • Scalp Biopsy: If the diagnosis is unclear, a 4-mm “punch” biopsy of the scalp may be performed. This allows a pathologist to look at the hair follicles under a microscope to check for inflammation or scarring [10][11].

Branch 3: The Endocrine & Genetic Workup

This branch is vital for safety, as it looks for “hidden” hormone problems that often accompany rare genetic hair loss syndromes.

  • Adrenal Screening: Testing morning cortisol and ACTH levels can be evaluated if NFKB2 deficiency is suspected [12]. Because a morning cortisol can be indeterminate, an endocrinologist may need dynamic testing or longitudinal surveillance. If these are low, you may need an ACTH stimulation test to see if your adrenal glands can respond to stress [13].
  • Calcium & PTH: Low calcium or low parathyroid hormone can be a major clue for APECED [14][15].
  • Anti-Interferon Antibodies: A specialized blood test for anti-type-I-interferon antibodies can help identify APECED [16].
  • Targeted Genetic Panels: Finally, your team may use a “next-generation sequencing” panel to look for specific glitches in genes like NFKB2, AIRE, or FOXN1 [17][18]. (Note: Genetic testing may yield variants of uncertain significance and should ideally involve genetic counseling.)

Coordinating Your Care

Because these tests span so many specialties, it is easy for information to get lost. Patients with this clinical picture are best served by a multidisciplinary team where the immunologist, dermatologist, and endocrinologist share notes [19]. This ensures that while you are treating the hair loss (which is visible), you are not overlooking the antibody or hormone issues (which are invisible but potentially life-threatening).

Common questions in this guide

How do doctors confirm an antibody deficiency when I also have hair loss?
An immunologist usually repeats blood measurements of IgG, IgA, and IgM to confirm that antibody levels remain low for the person’s age. Testing may also include vaccine-response measurements and flow cytometry, which counts immune-cell types and may assess switched-memory B cells. T-cell function testing is considered when a more severe immune disorder is suspected.
What tests determine the type of alopecia?
A dermatologist examines the pattern of loss, may perform a gentle hair-pull test, and can use trichoscopy to view features such as exclamation-mark hairs or black dots. If the diagnosis remains uncertain, a small scalp punch biopsy can be examined under a microscope. The workup may also rule out fungal infection, temporary shedding, and common pattern hair loss.
Why are adrenal and calcium tests part of this workup?
Low morning cortisol or abnormal ACTH can point to adrenal insufficiency in people with possible NFKB2 deficiency, although an indeterminate result may require an ACTH stimulation test or repeat monitoring. Low calcium or parathyroid hormone, along with anti-type-I-interferon antibodies, can support evaluation for APECED. An endocrinologist should interpret these tests.
Can genetic testing explain hair loss and antibody deficiency?
A targeted genetic panel may look for changes in NFKB2, AIRE, or FOXN1, which are linked to immune or hormone-related syndromes that can include hair loss. A result called a variant of uncertain significance does not prove that a gene caused the symptoms. Genetic counseling can help explain what a result means and whether it changes monitoring or treatment.
Is a vaccine challenge safe and useful if I have low antibodies?
An immunologist must decide whether vaccine-response testing is appropriate and how to interpret it. Immunoglobulin replacement can make the results difficult to interpret, and vaccination may be unsafe when a significant T-cell deficiency is suspected. Do not arrange this testing without specialist guidance.
Why do I need several specialists for hair loss with antibody deficiency?
An immunologist evaluates antibody and T-cell function, a dermatologist identifies the type of hair loss, and an endocrinologist checks for adrenal or parathyroid problems. Sharing results across these specialties helps distinguish a CVID-related presentation from rare genetic syndromes and reduces the risk of missing a serious hormone problem.

Get notified when new evidence is published on Alopecia antibody deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Antibody deficiency testing for primary immunodeficiency: A practical review for the clinician.

    Marsh RA, Orange JS

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2019; (123(5)):444-453 doi:10.1016/j.anai.2019.08.012.

    PMID: 31446132
  2. 2

    Primary Immunodeficiency: Specific antibody deficiency with normal IgG.

    Hatcher VR, Alix VC, Hellu TS, Schuldt MM

    Allergy and asthma proceedings 2024; (45(5)):321-325 doi:10.2500/aap.2024.45.240057.

    PMID: 39294904
  3. 3

    Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency Disorders.

    Ameratunga R, Longhurst H, Leung E, et al.

    Clinical immunology (Orlando, Fla.) 2024; (266()):110320 doi:10.1016/j.clim.2024.110320.

    PMID: 39025346
  4. 4

    EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.

    van Dongen JJM, van der Burg M, Kalina T, et al.

    Frontiers in immunology 2019; (10()):1271 doi:10.3389/fimmu.2019.01271.

    PMID: 31263462
  5. 5

    Current concepts: Common variable immunodeficiency.

    Cunningham-Rundles C

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2026; (136(4)):376-386 doi:10.1016/j.anai.2025.11.009.

    PMID: 41274495
  6. 6

    Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2.

    Klemann C, Camacho-Ordonez N, Yang L, et al.

    Frontiers in immunology 2019; (10()):297 doi:10.3389/fimmu.2019.00297.

    PMID: 30941118
  7. 7

    Hair and Nail Conditions: Alopecia Evaluation.

    Wu S

    FP essentials 2022; (517()):11-16.

    PMID: 35679467
  8. 8

    Trichoscopy of alopecia areata: An update.

    Waśkiel A, Rakowska A, Sikora M, et al.

    The Journal of dermatology 2018; (45(6)):692-700 doi:10.1111/1346-8138.14283.

    PMID: 29569271
  9. 9

    Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.

    Zhang X, Ye Y, Zhu Z, et al.

    Experimental dermatology 2020; (29(3)):223-230 doi:10.1111/exd.13799.

    PMID: 30307062
  10. 10

    Scalp Biopsies for Alopecia.

    Brunetti T, Misciali C, Rapparini L, et al.

    Dermatopathology (Basel, Switzerland) 2026; (13(3)) doi:10.3390/dermatopathology13030044.

    PMID: 42782841
  11. 11

    Alopecia areata.

    Pratt CH, King LE, Messenger AG, et al.

    Nature reviews. Disease primers 2017; (3()):17011 doi:10.1038/nrdp.2017.11.

    PMID: 28300084
  12. 12

    Deficient anterior pituitary with common variable immune deficiency (DAVID syndrome): a new case and literature reports.

    Mac TT, Castinetti F, Bar C, et al.

    Journal of neuroendocrinology 2023; (35(6)):e13287 doi:10.1111/jne.13287.

    PMID: 37322808
  13. 13

    Symptomatic hypoglycemia in a child with common variable immunodeficiency: Deficient anterior pituitary with variable immune deficiency (DAVID) syndrome.

    Nogueira M, Pinheiro M, Maia R, et al.

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2020; (29(3)):111-113 doi:10.1297/cpe.29.111.

    PMID: 32694887
  14. 14

    Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach.

    Bjørklund G, Pivin M, Hangan T, et al.

    Autoimmunity reviews 2022; (21(8)):103135 doi:10.1016/j.autrev.2022.103135.

    PMID: 35690244
  15. 15

    Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review.

    Sandru F, Petca RC, Dumitrascu MC, et al.

    Biomedicines 2024; (12(1)) doi:10.3390/biomedicines12010132.

    PMID: 38255237
  16. 16

    Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

    Ferre EM, Rose SR, Rosenzweig SD, et al.

    JCI insight 2016; (1(13)).

    PMID: 27588307
  17. 17

    The Rapidly Expanding Genetic Spectrum of Common Variable Immunodeficiency-Like Disorders.

    Ameratunga R, Edwards ESJ, Lehnert K, et al.

    The journal of allergy and clinical immunology. In practice 2023; (11(6)):1646-1664 doi:10.1016/j.jaip.2023.01.048.

    PMID: 36796510
  18. 18

    Perspective: Application of the American College of Medical Genetics Variant Interpretation Criteria to Common Variable Immunodeficiency Disorders.

    Ameratunga R, Allan C, Lehnert K, Woon ST

    Clinical reviews in allergy & immunology 2021; (61(2)):226-235 doi:10.1007/s12016-020-08828-z.

    PMID: 33818703
  19. 19

    Common Variable Immunodeficiency Disorders: A perspective from New Zealand.

    Ameratunga R, J Longhurst H, Lehnert K, et al.

    Clinical reviews in allergy & immunology 2025; (68(1)):105 doi:10.1007/s12016-025-09099-2.

    PMID: 41324804

This diagnostic roadmap is for informational purposes only and does not constitute medical advice. Your immunologist, dermatologist, endocrinologist, and genetic counselor should interpret your results and decide which tests are appropriate and safe.